Evidence map›Paper›PMID 27877175›Full record

ArticleFrontiers in immunology2016

Thymocytes in

Akira Takeda, Mohammad Shahadat Hossain, Pia Rantakari, Szandor Simmons, Naoko Sasaki, Marko Salmi, Sirpa Jalkanen, Masayuki Miyasaka

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Akira TakedaMediCity Research Laboratory, University of Turku , Turku , Finland.
Mohammad Shahadat HossainMediCity Research Laboratory, University of Turku , Turku , Finland.
Pia RantakariMediCity Research Laboratory, University of Turku , Turku , Finland.
Szandor SimmonsDepartment of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Japan; WPI Immunology Frontier Research Center, Osaka University, Suita, Japan.
Naoko SasakiDepartment of Microbiology and Immunology, Graduate School of Medicine, Osaka University , Suita , Japan.
Marko SalmiMediCity Research Laboratory, University of Turku, Turku, Finland; Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland.
Sirpa JalkanenMediCity Research Laboratory, University of Turku , Turku , Finland.
Masayuki MiyasakaMediCity Research Laboratory, University of Turku, Turku, Finland; WPI Immunology Frontier Research Center, Osaka University, Suita, Japan; Interdisciplinary Program for Biomedical Sciences, Institute for Academic Initiatives, Osaka University, Suita, Japan.
University of Turku · FIOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cell emigration from the thymus is essential for immunological homeostasis. While stromal cell-produced sphingosine-1-phosphate (S1P) has been shown to promote thymocyte egress

Indexed as

egressLyve1S1PR1sphingosine-1-phosphatethymus

Identifiers

PMID27877175
PMCPMC5099144
OpenAlexW2554851081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.